Evidence map›Paper›PMID 31871475›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2019

Suppressive Effect of Huzhentongfeng on Experimental Gouty Arthritis: An

Zi-Cong Wu, Qiang Xue, Zhen-Ling Zhao, Peng-Jun Zhou, Qun Zhou, Zhen Zhang, Jian-Ping Deng, Ke Yang, Hua Fan, Yi-Fei Wang and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Tongbixiao Pills Improve Gout by Reducing Uric Acid Levels and Inhibiting Inflammation.Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Zi-Cong Wu *Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Department of Pharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID https://orcid.org/0000-0002-8472-3016
Qiang Xue *Chenguang Biotech Group Co., Ltd., Handan 056000, China.ORCID https://orcid.org/0000-0002-7861-3603
Zhen-Ling ZhaoGuangzhou (Jinan) Biomedical Research and Development Center, Guangzhou 510632, China.
Peng-Jun ZhouCollege of Life Science and Technology, Jinan University, Guangzhou 510632, China.
Qun ZhouHuazhong University of Science and Technology, Wuhan 430074, China.
Zhen ZhangGuangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Department of Pharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Jian-Ping DengGuangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Department of Pharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Ke YangGuangzhou (Jinan) Biomedical Research and Development Center, Guangzhou 510632, China.
Hua FanGuangzhou (Jinan) Biomedical Research and Development Center, Guangzhou 510632, China.
Yi-Fei WangGuangzhou (Jinan) Biomedical Research and Development Center, Guangzhou 510632, China.
Zhi-Ping WangGuangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Department of Pharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID https://orcid.org/0000-0002-2367-0491
Guangdong Pharmaceutical University · CNJinan University · CNHuazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuzhentongfeng (HZTF) is an extract from four Chinese medical herbs for treating gout. This study aims to evaluate its antigout activity and preliminary explore its mechanism

methodsThe rats were intragastrically administered with HZTF for 5 days and then injected 0.1 ml (10 mg) of MSU crystals to their joints for generating a gout model to analyze the paw volume and histopathology of joint synovial tissues of rats with different doses. We also investigated the antioxidant capacity of HZTF

resultsHZTF could significantly suppress the paw swelling and neutrophil infiltration induced by MSU intra-articular injection in rats compared with the control group. HZTF also showed inhibition effects of inflammatory cytokines (IL-1

conclusionThe results prove that HZTF possessed the potential preventive effect against gout arthritis, and the effect may be attributed to its preventing effect on neutrophil infiltration and proinflammatory cytokines secretion such as IL-1

Identifiers

PMID31871475
PMCPMC6913320
OpenAlexW2993745928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.